In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of consolidated audited financial results for the for the quarter and year ended 31 March 2026 along with information on standalone financial results. The same was published on Saturday, 16 May 2026 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).
The above information is a part of company’s filings submitted to BSE.
